The NFLPA Review Must Clear Up the Questions Around Jalen Hurts’ Care

The next step in the NFLPA’s Jalen Hurts review request should be a defined examination of decisions, records and responsibility. The practical question is what happens after the league says scrutiny is welcome?

NFL.com reports that Goodell welcomed further review while defending league protocols. Separately, the NFLPA requested an investigation and said it knew of none. Neither statement confirms that a formal investigation has begun.

For the Eagles, a useful response would explain how those public positions become a process. A named reviewer, agreed scope and date for a progress update would give players something concrete to assess. Another broad assurance would leave the central question untouched.

YouTube videoWatch on YouTube ↗

Start with the decisions in the team’s timeline

The Eagles’ October 15 statement supplies the team’s account of the sequence. It says Hurts requested calf treatment October 8. According to the team, a Saturday ultrasound in London showed a superficial clot, and medical staff cleared him to play.

The same statement says follow-up imaging was recommended within 72 hours of the game and return flight. It says Wednesday’s follow-up showed clot movement. Those are attributed statements from the organization, rather than findings from an independent examination.

That sequence gives a prospective review identifiable decisions to examine. What information was available at each point? Who received it? Who held responsibility for the next step? Records and interviews could establish those answers more reliably than competing interpretations of press-conference language.

The review should also distinguish a recommendation from its execution. An instruction can be clear on paper while responsibility for arranging the next appointment remains disputed. Conversely, a public statement can leave out detail that the underlying records resolve. The task is to establish which occurred here, without guessing.

The medical reasoning belongs with qualified reviewers who have appropriate access. A timeline alone cannot establish whether a decision met a clinical standard. Nor can a later development, viewed without the earlier information, settle what the original decision should have been.

Set a reporting date without inventing a verdict date

A credible process can offer a next update before promising a completion date. The parties could identify when they expect to announce the scope, who will participate and which questions remain unresolved. That would prevent silence from becoming the only public measure of progress.

A short deadline for a verdict could create its own problem. Reviewers may need records, consent and interviews before reaching conclusions. The better accountability demand is an explanation of the work outstanding and a date to report its status.

That distinction also helps readers follow changes. An initial document request, an agreed review and a completed finding are different stages. Future announcements should identify the actual stage reached. Calling all three an investigation would blur the very process the union wants clarified.

The examination should preserve room for more than one result. Reviewers might find that stated procedures were followed, identify a communication problem or recommend a change. Those are possible outcomes, not conclusions supported by the public statements now available.

Keep Hurts’ care separate from football pressure

The October 19 joint statement from the Eagles and agent Nicole Lynn describes deep vein thrombosis and bilateral pulmonary emboli. It says Hurts is clinically stable, receiving anticoagulation treatment and prohibited from contact football during treatment. It expresses a favorable recovery expectation without a fixed return date.

That later statement supplies the current disclosed medical status. It should not be stretched into either approval or condemnation of every earlier decision. Nor does participation in a joint update reveal Hurts’ private views about a potential review.

Any public report should explain its privacy limits. Reviewers can describe their scope and process without promising unrestricted access to a player’s medical history. Where consent limits disclosure, stating that boundary clearly would be more useful than allowing a missing detail to invite speculation.

The broader player-protection question is whether responsibility can be traced through the entire sequence of care. If a review recommends a procedural change, the next accountability step would identify who implements it and how completion gets checked.

The National Football Show discussion raises the demand for answers. The next announcement to watch is a concrete response to the union’s request: who will review the record, under what scope, and when the parties will report progress.